S&P 500   3,107.60 (-0.03%)
DOW   27,813.13 (-0.03%)
QQQ   201.91 (-0.12%)
CGC   19.80 (+12.25%)
BABA   184.67 (+1.27%)
GE   11.59 (+1.76%)
ACB   2.96 (+12.12%)
F   8.71 (-0.23%)
PRI   130.82 (-0.53%)
BAC   32.93 (+0.73%)
DIS   146.79 (-0.10%)
S&P 500   3,107.60 (-0.03%)
DOW   27,813.13 (-0.03%)
QQQ   201.91 (-0.12%)
CGC   19.80 (+12.25%)
BABA   184.67 (+1.27%)
GE   11.59 (+1.76%)
ACB   2.96 (+12.12%)
F   8.71 (-0.23%)
PRI   130.82 (-0.53%)
BAC   32.93 (+0.73%)
DIS   146.79 (-0.10%)
S&P 500   3,107.60 (-0.03%)
DOW   27,813.13 (-0.03%)
QQQ   201.91 (-0.12%)
CGC   19.80 (+12.25%)
BABA   184.67 (+1.27%)
GE   11.59 (+1.76%)
ACB   2.96 (+12.12%)
F   8.71 (-0.23%)
PRI   130.82 (-0.53%)
BAC   32.93 (+0.73%)
DIS   146.79 (-0.10%)
S&P 500   3,107.60 (-0.03%)
DOW   27,813.13 (-0.03%)
QQQ   201.91 (-0.12%)
CGC   19.80 (+12.25%)
BABA   184.67 (+1.27%)
GE   11.59 (+1.76%)
ACB   2.96 (+12.12%)
F   8.71 (-0.23%)
PRI   130.82 (-0.53%)
BAC   32.93 (+0.73%)
DIS   146.79 (-0.10%)
Log in

DiaSorin Stock Price, Forecast & Analysis (OTCMKTS:DSRLF)

$114.75
0.00 (0.00 %)
(As of 10/18/2019)
Today's Range
$114.75
Now: $114.75
$114.75
50-Day Range
$114.75
MA: $114.75
$114.75
52-Week Range
$80.10
Now: $114.75
$119.00
VolumeN/A
Average Volume5 shs
Market Capitalization$6.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.88
DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:DSRLF
CUSIPN/A
CIKN/A
Phone390-161-4871

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$790.32 million
Cash Flow$4.41 per share
Book Value$14.88 per share

Profitability

Miscellaneous

Employees1,928
Market Cap$6.42 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive DSRLF News and Ratings via Email

Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.


DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions

What is DiaSorin's stock symbol?

DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."

Has DiaSorin been receiving favorable news coverage?

Media headlines about DSRLF stock have trended positive this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. DiaSorin earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for DiaSorin.

Who are some of DiaSorin's key competitors?

What other stocks do shareholders of DiaSorin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DiaSorin investors own include Nektar Therapeutics (NKTR), Cara Therapeutics (CARA), Accelerate Diagnostics (AXDX), Valero Energy (VLO), CenterPoint Energy (CNP) and Vast Resources (VAST).

Who are DiaSorin's key executives?

DiaSorin's management team includes the folowing people:
  • Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
  • Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)
  • Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
  • Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
  • Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department

How do I buy shares of DiaSorin?

Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is DiaSorin's stock price today?

One share of DSRLF stock can currently be purchased for approximately $114.75.

How big of a company is DiaSorin?

DiaSorin has a market capitalization of $6.42 billion and generates $790.32 million in revenue each year. DiaSorin employs 1,928 workers across the globe.View Additional Information About DiaSorin.

What is DiaSorin's official website?

The official website for DiaSorin is http://www.diasoringroup.com/.

How can I contact DiaSorin?

DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]


MarketBeat Community Rating for DiaSorin (OTCMKTS DSRLF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DSRLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSRLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Featured Article: Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel